|
1
|
Gridelli C, Rossi A, Carbone DP, Guarize
J, Karachaliou N, Mok T, Petrella F, Spaggiari L and Rosell R:
Non-small-cell lung cancer. Nat Rev Dis Primers. 1:150092015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brahmer J, Reckamp KL, Baas P, Crinò L,
Eberhardt WE, Poddubskaya E, Antonia S, Pluzanski A, Vokes EE,
Holgado E, et al: Nivolumab versus docetaxel in advanced
squamous-cell non-small-cell lung cancer. N Engl J Med.
373:123–135. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chaffer CL, San Juan BP, Lim E and
Weinberg RA: EMT, cell plasticity and metastasis. Cancer Metastasis
Rev. 35:645–654. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang S, Yan Y, Cheng Z, Hu Y and Liu T:
Sotetsuflavone suppresses invasion and metastasis in non-small-cell
lung cancer A549 cells by reversing EMT via the TNF-α/NF-κB and
PI3K/AKT signaling pathway. Cell Death Discov. 4:262018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xu S, Sui S, Zhang J, Bai N, Shi Q, Zhang
G, Gao S, You Z, Zhan C, Liu F and Pang D: Downregulation of long
noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition
via the PI3K-AKT pathway in breast cancer. Int J Clin Exp Pathol.
8:4881–4891. 2015.PubMed/NCBI
|
|
8
|
Zhu Y, Zhang X, Qi L, Cai Y, Yang P, Xuan
G and Jiang Y: HULC long noncoding RNA silencing suppresses
angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling
pathway in human gliomas. Oncotarget. 7:14429–14440.
2016.PubMed/NCBI
|
|
9
|
Cheetham SW, Gruhl F, Mattick JS and
Dinger ME: Long noncoding RNAs and the genetics of cancer. Br J
Cancer. 108:2419–2425. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lin A, Li C, Xing Z, Hu Q, Liang K, Han L,
Wang C, Hawke DH, Wang S, Zhang Y, et al: The LINK-A lncRNA
activates normoxic HIF1α signalling in triple-negative breast
cancer. Nat Cell Biol. 18:213–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin A, Hu Q, Li C, Xing Z, Ma G, Wang C,
Li J, Ye Y, Yao J, Liang K, et al: The LINK-A lncRNA interacts with
ptdIns (3, 4, 5) P 3 to hyperactivate AKT and confer resistance to
AKT inhibitors. Nat Cell Biol. 19:238–251. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qiao M, Sheng S and Pardee AB: Metastasis
and AKT activation. Cell Cycle. 7:2991–2996. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ramankulov A, Lein M, Johannsen M,
Schrader M, Miller K and Jung K: Plasma matrix metalloproteinase-7
as a metastatic marker and survival predictor in patients with
renal cell carcinomas. Cancer Sci. 99:1188–1194. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou D, Xie M, He B, Gao Y, Yu Q, He B and
Chen Q: Microarray data re-annotation reveals specific lncRNAs and
their potential functions in non-small cell lung cancer subtypes.
Mol Med Rep. 16:5129–5136. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun M, Liu XH, Lu KH, Nie FQ, Xia R, Kong
R, Yang JS, Xu TP, Liu YW, Zou YF, et al: EZH2-mediated epigenetic
suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell
proliferation and metastasis by affecting the
epithelial-mesenchymal transition. Cell Death Dis. 5:e12982014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Z, Wang J, Wang S, Chang H, Zhang T
and Qu J: LncRNA CCAT2 promotes tumorigenesis by over-expressed
Pokemon in non-small cell lung cancer. Biomed Pharmacother.
87:692–697. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shi X, Chen Y, Chen J, Feng F, Li J and He
J: Antisense long noncoding RNA LOC285194 is downregulated in NSCLC
and associated with poor prognosis. Chest. 149:A2562016. View Article : Google Scholar
|
|
19
|
Matsuoka Y, Nishi D, Tanima Y, Itakura M,
Kojima M, Hamazaki K, Noguchi H and Hamazaki T: Serum pro-BDNF/BDNF
as a treatment biomarker for response to docosahexaenoic acid in
traumatized people vulnerable to developing psychological distress:
A randomized controlled trial. Transl Psychiatry. 5:e5962015.
View Article : Google Scholar : PubMed/NCBI
|
